PH94B Recruiting Phase 3 Trials for Social Anxiety Disorder (SAD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05011396PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
NCT05030350Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)